Search hospitals > Georgia > Lawrenceville
Gwinnett Medical Center
Claim this profileLawrenceville, Georgia 30045
Global Leader in Breast Cancer
Global Leader in Thyroid Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
128 reported clinical trials
10 medical researchers
Summary
Gwinnett Medical Center is a medical facility located in Lawrenceville, Georgia. This center is recognized for care of Breast Cancer, Thyroid Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Gwinnett Medical Center is involved with conducting 128 clinical trials across 200 conditions. There are 10 research doctors associated with this hospital, such as Rodolfo E. Bordoni, Amelia B Zelnak, MD, Sreekanth C. Reddy, and Gena H. Volas-Redd.Area of expertise
1Breast Cancer
Global LeaderER positive
PR positive
HER2 positive
2Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Rodolfo E. BordoniNorthside Hospital3 years of reported clinical research
Studies Thyroid Cancer
Studies Lung Cancer
14 reported clinical trials
29 drugs studied
Amelia B Zelnak, MDNorthside Hospital1 year of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
52 drugs studied
Sreekanth C. ReddyNorthside Hospital6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
7 reported clinical trials
15 drugs studied
Gena H. Volas-ReddNorthside Hospital2 years of reported clinical research
Studies Thyroid Cancer
Studies Glioblastoma
6 reported clinical trials
13 drugs studied
Clinical Trials running at Gwinnett Medical Center
Breast Cancer
Lung Cancer
Cutaneous Melanoma
Skin Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Breast cancer
Thyroid Cancer
Melanoma
ALK Gene Rearrangement
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Gwinnett Medical Center?
Gwinnett Medical Center is a medical facility located in Lawrenceville, Georgia. This center is recognized for care of Breast Cancer, Thyroid Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Gwinnett Medical Center is involved with conducting 128 clinical trials across 200 conditions. There are 10 research doctors associated with this hospital, such as Rodolfo E. Bordoni, Amelia B Zelnak, MD, Sreekanth C. Reddy, and Gena H. Volas-Redd.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.